Scott James Weir

age ~69

from Overland Park, KS

Get Report

Also known as:

Connected to:

Scott Weir Phones & Addresses

License #:

9303 - Expired

Category:

Pharmacy

Issued Date:

Jul 25, 1980

Effective Date:

Jul 26, 1988

Type:

Pharmacist

Prodrugs Of 6-Cyclohexyl-1-Hydroxy-4-Methylpyridin-2-(1H)- One And Derivatives Thereof
view source
US Patent:

20120142637, Jun 7, 2012
Filed:

Dec 2, 2011
Appl. No.:

13/310087
Inventors:

Mehmet Tanol - Lawrence KS, US
Scott J. Weir - Lawrence KS, US
Assignee:

THE UNIVERSITY OF KANSAS - Lawrence KS
International Classification:

A61K 31/675
C07F 9/6596
C07F 9/59
A61P 35/02
A61P 35/00
A61P 17/00
A61P 29/00
C07F 9/58
A61P 31/10
US Classification:

514 89, 546 24
Abstract:

A prodrug can have a structure of Formula 10 or derivative thereof or stereoisomer thereof or pharmaceutically acceptable salt thereof. The prodrug can be included in a pharmaceutical composition for use in treatment of fungus, cancer, dermatitis, superficial mycoses; inflammation, tinea pedis, tinea cruris, and tinea corporis, , and , candidiasis (moniliasis), , tinea (pityriasis) vesicolor, , acute myeloid leukemia, acute lymphoid leukemia, chronic myelogenous leukemia, lymphoma or multiple myeloma.

Methods For Overcoming Wnt/Beta-Catenin Anti-Cancer Resistance In Leukemia Stem Cells
view source
US Patent:

20210113597, Apr 22, 2021
Filed:

Jun 26, 2020
Appl. No.:

16/914086
Inventors:

Linheng Li - Kansas City MO, US
John M. Perry - Olathe KS, US
Fang Tao - Overland Park KS, US
Xi C. He - Kansas City MO, US
Anuradha Roy - Kansas City MO, US
Scott J. Weir - Overland Park KS, US
Tara Lin - Mission Hills KS, US
International Classification:

A61K 31/704
A61K 39/395
C07K 16/28
A61P 35/02
Abstract:

The present disclosure provides, inter alia, methods for treating cancers including leukemia using low doses of an anthracycline such as doxorubicin.

Methods Of Forming Cyclopirox Or Derivatives Thereof In A Subject By Administration Of Prodrug
view source
US Patent:

20160095870, Apr 7, 2016
Filed:

Dec 11, 2015
Appl. No.:

14/966323
Inventors:

- Lawrence KS, US
Scott Weir - Olathe KS, US
International Classification:

A61K 31/675
Abstract:

A method of forming a compound in a subject can include: providing a composition having a prodrug compound represented by a structure of Formula 1 or stereoisomer thereof or pharmaceutically acceptable salt thereof; and administering the composition to a subject such that the prodrug compound has a phosphoryloxyalkyl prodrug moiety removed therefrom to form the compound in the subject and to form the separate phosphoryloxyalkyl compound. The prodrug can be included in a pharmaceutical composition for use in treatment of fungus, various cancers (e.g., bladder, breast, etc.), dermatitis, superficial mycoses; inflammation, tinea pedis, tinea cruris, and tinea corporis, , and , candidiasis (moniliasis), , tinea (pityriasis) vesicolor, , acute myeloid leukemia, acute lymphoid leukemia, chronic myelogenous leukemia, lymphoma or multiple myeloma.

Method Of Treatment With Prodrugs Of 6-Cyclohexyl-1-Hydroxy-4-Methylpyridin In-2-1H-One And Derivatives Thereof
view source
US Patent:

20150111858, Apr 23, 2015
Filed:

Oct 21, 2013
Appl. No.:

14/059287
Inventors:

Mehmet Tanol - Lawrence KS, US
Scott J. Weir - Lawrence KS, US
Assignee:

The University of Kansas - Lawrence KS
International Classification:

C07F 9/6596
C07F 9/59
US Classification:

514 89
Abstract:

A prodrug can have a structure of Formula 10 or derivative thereof or stereoisomer thereof or pharmaceutically acceptable salt thereof. The prodrug can be included in a pharmaceutical composition for use in treatment of fungus, cancer, dermatitis, superficial mycoses; inflammation, tinea pedis, tinea cruris, and tinea corporis, , and , candidiasis (moniliasis), , tinea () vesicolor, , acute myeloid leukemia, acute lymphoid leukemia, chronic myelogenous leukemia, lymphoma or multiple myeloma.